Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions.

Abstract excerpt

Growing evidence supports a major role of chronic inflammation and platelet activation in the development of atherosclerosis and cardiovascular (CV) disease. Because CV dysfunction is, at least in part, reversible, identifying these early stages may enhance the development of new therapeutic and preventive interventions. Technological advances have led to appreciation of underlying pathophysiology in vivo via...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atherosclerosis
• Share to Inflammation